VanEck Biotech ETF
BBH
BBH
79 hedge funds and large institutions have $161M invested in VanEck Biotech ETF in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 26 increasing their positions, 25 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
1% more funds holding
Funds holding: 78 → 79 (+1)
4% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 25
Holders
79
Holding in Top 10
–
Calls
$6.2M
Puts
$1.18M
Top Buyers
| 1 | +$68.9M | |
| 2 | +$2.95M | |
| 3 | +$2.53M | |
| 4 |
Nomura Asset Management
Tokyo,
Japan
|
+$1.07M |
| 5 |
Jane Street
New York
|
+$910K |
Top Sellers
| 1 | -$3.38M | |
| 2 | -$1.17M | |
| 3 | -$925K | |
| 4 |
Millennium Management
New York
|
-$843K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$676K |